The company is working on expanding its flagship LiverMultiScan product, a tool used to diagnose and assess liver disease.
The second tranche of series C funding brings the company’s total series C round to $55 million, according to a March 15 Perspectum news release.
Since the company’s inception, it has raised $140 million. Oppenheimer led the latest series C investment round.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
